Sarepta Therapeutics: 1Q Earnings Snapshot
CAMBRIDGE, Mass. (AP) _ Sarepta Therapeutics Inc. (SRPT) on Wednesday reported a loss of $17.5 million in its first quarter.
On a per-share basis, the Cambridge, Massachusetts-based company said it had a loss of 23 cents.
The results topped Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of $2.29 per share.
The biopharmaceutical company posted revenue of $113.7 million in the period, also exceeding Street forecasts. Seven analysts surveyed by Zacks expected $113.4 million.
Sarepta Therapeutics shares have declined 5% since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $122.57, an increase of almost 1% in the last 12 months.